PATENT CLAIM ANALYSIS

Application Number: 15990711
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["546", "113000"]

Abstract:
The present invention relates to a process for the preparation substantially pure propane-1-sulfonicacid-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide or Vemurafenib of Formula (I). The present invention further relates to a process for the preparation substantially pure propane-1-sulfonic acid-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3 -b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide trifluoro methane sulfonic acid salt or Vemurafenib triflate of Formula (VII)

Claim (Index 8):
A process for the preparation of substantially pure Vemurafenib comprising the steps of\u2014\n a) treating Vemurafenib or Vemurafenib hydrate or solvate or salt with an alkaline solution; and \n b) optionally, reacting Vemurafenib or Vernurafenib hydrate or solvate or salt with an acid forming salt to form the corresponding salt, followed by basification with an alkaline solution to obtain substantially pure Vemurafenib(I).

Metadata:
- Claim Count in Document: 6.0
- Percentile: 93.0
- Lexical Diversity: 1.82222
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15527721', '13816376', '14373163', '16068575', '15366229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7287308392595878
- 35 USC 102 Novelty (BERT): 0.5248035154159292
- Combined Prediction Score: 0.7083381068752219
- Mean Citation Score: 257.726786
- Max Citation Score: 326.7036700000001
- Similarity Product: 240.64395861583773

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test